Stay updated on Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial page.

Latest updates to the Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check20 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check63 days agoChange DetectedThe web page has updated its version from v2.14.4 to v2.15.0, indicating a significant revision. Additionally, a phrase has been removed and replaced with a similar one, but the core content remains unchanged.SummaryDifference1.0%
- Check70 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check113 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
Stay in the know with updates to Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial page.